Myriad Genetics Statistics
Total Valuation
MYGN has a market cap or net worth of $1.63 billion. The enterprise value is $1.68 billion.
Important Dates
The next confirmed earnings date is Thursday, November 7, 2024, after market close.
Earnings Date | Nov 7, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
MYGN has 90.82 million shares outstanding. The number of shares has increased by 7.39% in one year.
Shares Outstanding | 90.82M |
Shares Change (YoY) | +7.39% |
Shares Change (QoQ) | +0.78% |
Owned by Insiders (%) | 2.21% |
Owned by Institutions (%) | 96.60% |
Float | 83.27M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 122.38 |
PS Ratio | 1.96 |
Forward PS | 1.86 |
PB Ratio | 2.21 |
P/FCF Ratio | n/a |
PEG Ratio | 2.15 |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 2.09 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.96, with a Debt / Equity ratio of 0.19.
Current Ratio | 1.96 |
Quick Ratio | 1.44 |
Debt / Equity | 0.19 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -32.28 |
Financial Efficiency
Return on equity (ROE) is -21.03% and return on invested capital (ROIC) is -7.08%.
Return on Equity (ROE) | -21.03% |
Return on Assets (ROA) | -5.68% |
Return on Capital (ROIC) | -7.08% |
Revenue Per Employee | $297,111 |
Profits Per Employee | -$57,481 |
Employee Count | 2,700 |
Asset Turnover | 0.71 |
Inventory Turnover | 10.21 |
Taxes
Income Tax | -1.40M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +15.47% in the last 52 weeks. The beta is 1.94, so MYGN's price volatility has been higher than the market average.
Beta (5Y) | 1.94 |
52-Week Price Change | +15.47% |
50-Day Moving Average | 25.57 |
200-Day Moving Average | 23.83 |
Relative Strength Index (RSI) | 22.28 |
Average Volume (20 Days) | 730,277 |
Short Selling Information
The latest short interest is 4.49 million, so 4.95% of the outstanding shares have been sold short.
Short Interest | 4.49M |
Short Previous Month | 4.19M |
Short % of Shares Out | 4.95% |
Short % of Float | 5.40% |
Short Ratio (days to cover) | 6.48 |
Income Statement
In the last 12 months, MYGN had revenue of $802.20 million and -$155.20 million in losses. Loss per share was -$1.78.
Revenue | 802.20M |
Gross Profit | 554.10M |
Operating Income | -103.30M |
Pretax Income | -156.60M |
Net Income | -155.20M |
EBITDA | -49.00M |
EBIT | -103.30M |
Loss Per Share | -$1.78 |
Full Income Statement Balance Sheet
The company has $97.30 million in cash and $143.30 million in debt, giving a net cash position of -$46.00 million or -$0.51 per share.
Cash & Cash Equivalents | 97.30M |
Total Debt | 143.30M |
Net Cash | -46.00M |
Net Cash Per Share | -$0.51 |
Equity (Book Value) | 740.50M |
Book Value Per Share | 8.15 |
Working Capital | 142.70M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$92.80 million and capital expenditures -$32.80 million, giving a free cash flow of -$125.60 million.
Operating Cash Flow | -92.80M |
Capital Expenditures | -32.80M |
Free Cash Flow | -125.60M |
FCF Per Share | -$1.38 |
Full Cash Flow Statement Margins
Gross margin is 69.07%, with operating and profit margins of -12.88% and -19.35%.
Gross Margin | 69.07% |
Operating Margin | -12.88% |
Pretax Margin | -19.52% |
Profit Margin | -19.35% |
EBITDA Margin | -6.11% |
EBIT Margin | -12.88% |
FCF Margin | -17.61% |
Dividends & Yields
MYGN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -7.39% |
Shareholder Yield | -7.39% |
Earnings Yield | -9.50% |
FCF Yield | -7.69% |
Dividend Details Analyst Forecast
The average price target for MYGN is $28.18, which is 56.64% higher than the current price. The consensus rating is "Buy".
Price Target | $28.18 |
Price Target Difference | 56.64% |
Analyst Consensus | Buy |
Analyst Count | 12 |
Revenue Growth Forecast (5Y) | 7.51% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on March 26, 2009. It was a forward split with a ratio of 2:1.
Last Split Date | Mar 26, 2009 |
Split Type | Forward |
Split Ratio | 2:1 |
Scores
MYGN has an Altman Z-Score of 2.71 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.71 |
Piotroski F-Score | 4 |